Global Small Interfering RNA (siRNA) Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Small Interfering RNA (siRNA) Therapeutics Market Overview

• 1.1 Product Overview and Scope of Small Interfering RNA (siRNA) Therapeutics
• 1.2 Classification of Small Interfering RNA (siRNA) Therapeutics by Types
  • 1.2.1 Global Small Interfering RNA (siRNA) Therapeutics Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Types in 2018
  • 1.2.3 Liposome Based Systemic Therapy
  • 1.2.4 Nanoparticle Based Systemic Therapy
  • 1.2.5 Other
• 1.3 Global Small Interfering RNA (siRNA) Therapeutics Market by Application
  • 1.3.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Hospital
  • 1.3.3 Research Institutions
  • 1.3.4 Pharmaceutical and Biotechnology Companies
  • 1.3.5 Academic Institutions
  • 1.3.6 Other
• 1.4 Global Small Interfering RNA (siRNA) Therapeutics Market by Regions
  • 1.4.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Small Interfering RNA (siRNA) Therapeutics Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Small Interfering RNA (siRNA) Therapeutics Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Small Interfering RNA (siRNA) Therapeutics Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Small Interfering RNA (siRNA) Therapeutics Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Small Interfering RNA (siRNA) Therapeutics Status and Prospect (2014-2024)
• 1.5 Global Market Size of Small Interfering RNA (siRNA) Therapeutics (2014-2024)

2 Company Profiles

• 2.1 GE
  • 2.1.1 Business Overview
  • 2.1.2 Small Interfering RNA (siRNA) Therapeutics Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 GE Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Genecon Biotechnologies
  • 2.2.1 Business Overview
  • 2.2.2 Small Interfering RNA (siRNA) Therapeutics Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 OPKO Health
  • 2.3.1 Business Overview
  • 2.3.2 Small Interfering RNA (siRNA) Therapeutics Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 OPKO Health Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Horizon Discovery
  • 2.4.1 Business Overview
  • 2.4.2 Small Interfering RNA (siRNA) Therapeutics Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Sanofi Genzyme
  • 2.5.1 Business Overview
  • 2.5.2 Small Interfering RNA (siRNA) Therapeutics Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Thermo Scientific
  • 2.6.1 Business Overview
  • 2.6.2 Small Interfering RNA (siRNA) Therapeutics Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Silent Therapeutics
  • 2.7.1 Business Overview
  • 2.7.2 Small Interfering RNA (siRNA) Therapeutics Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Arrowhead Research
  • 2.8.1 Business Overview
  • 2.8.2 Small Interfering RNA (siRNA) Therapeutics Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 AInylam Pharmaceuticals
  • 2.9.1 Business Overview
  • 2.9.2 Small Interfering RNA (siRNA) Therapeutics Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Arbutus Biopharma
  • 2.10.1 Business Overview
  • 2.10.2 Small Interfering RNA (siRNA) Therapeutics Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 Sylentis
  • 2.11.1 Business Overview
  • 2.11.2 Small Interfering RNA (siRNA) Therapeutics Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Sylentis Small Interfering RNA (siRNA) Therapeutics Revenue, Gross Margin and Market Share (2017-2018)

3 Global Small Interfering RNA (siRNA) Therapeutics Market Competition, by Players

• 3.1 Global Small Interfering RNA (siRNA) Therapeutics Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Small Interfering RNA (siRNA) Therapeutics Players Market Share
  • 3.2.2 Top 10 Small Interfering RNA (siRNA) Therapeutics Players Market Share
• 3.3 Market Competition Trend

4 Global Small Interfering RNA (siRNA) Therapeutics Market Size by Regions

• 4.1 Global Small Interfering RNA (siRNA) Therapeutics Revenue and Market Share by Regions
• 4.2 North America Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2014-2019)
• 4.3 Europe Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2014-2019)
• 4.5 South America Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2014-2019)

5 North America Small Interfering RNA (siRNA) Therapeutics Revenue by Countries

• 5.1 North America Small Interfering RNA (siRNA) Therapeutics Revenue by Countries (2014-2019)
• 5.2 USA Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2014-2019)
• 5.3 Canada Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2014-2019)

6 Europe Small Interfering RNA (siRNA) Therapeutics Revenue by Countries

• 6.1 Europe Small Interfering RNA (siRNA) Therapeutics Revenue by Countries (2014-2019)
• 6.2 Germany Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2014-2019)
• 6.3 UK Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2014-2019)
• 6.4 France Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2014-2019)
• 6.5 Russia Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2014-2019)
• 6.6 Italy Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Revenue by Countries

• 7.1 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Revenue by Countries (2014-2019)
• 7.2 China Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2014-2019)
• 7.3 Japan Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2014-2019)
• 7.4 Korea Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2014-2019)
• 7.5 India Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2014-2019)

8 South America Small Interfering RNA (siRNA) Therapeutics Revenue by Countries

• 8.1 South America Small Interfering RNA (siRNA) Therapeutics Revenue by Countries (2014-2019)
• 8.2 Brazil Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Small Interfering RNA (siRNA) Therapeutics by Countries

• 9.1 Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2014-2019)
• 9.3 UAE Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Small Interfering RNA (siRNA) Therapeutics Revenue and Growth Rate (2014-2019)

10 Global Small Interfering RNA (siRNA) Therapeutics Market Segment by Type

• 10.1 Global Small Interfering RNA (siRNA) Therapeutics Revenue and Market Share by Type (2014-2019)
• 10.2 Global Small Interfering RNA (siRNA) Therapeutics Market Forecast by Type (2019-2024)
• 10.3 Liposome Based Systemic Therapy Revenue Growth Rate (2014-2024)
• 10.4 Nanoparticle Based Systemic Therapy Revenue Growth Rate (2014-2024)
• 10.5 Other Revenue Growth Rate (2014-2024)

11 Global Small Interfering RNA (siRNA) Therapeutics Market Segment by Application

• 11.1 Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Application (2014-2019)
• 11.2 Small Interfering RNA (siRNA) Therapeutics Market Forecast by Application (2019-2024)
• 11.3 Hospital Revenue Growth (2014-2019)
• 11.4 Research Institutions Revenue Growth (2014-2019)
• 11.5 Pharmaceutical and Biotechnology Companies Revenue Growth (2014-2019)
• 11.6 Academic Institutions Revenue Growth (2014-2019)
• 11.7 Other Revenue Growth (2014-2019)

12 Global Small Interfering RNA (siRNA) Therapeutics Market Size Forecast (2019-2024)

• 12.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size Forecast (2019-2024)
• 12.2 Global Small Interfering RNA (siRNA) Therapeutics Market Forecast by Regions (2019-2024)
• 12.3 North America Small Interfering RNA (siRNA) Therapeutics Revenue Market Forecast (2019-2024)
• 12.4 Europe Small Interfering RNA (siRNA) Therapeutics Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Small Interfering RNA (siRNA) Therapeutics Revenue Market Forecast (2019-2024)
• 12.6 South America Small Interfering RNA (siRNA) Therapeutics Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Small Interfering RNA (siRNA) Therapeutics Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology